治疗性腺相关病毒基因转移至神经系统：临床现实 - Suppr

Suppr

超能文献

Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality.

作者信息

Hudry Eloise, Vandenberghe Luk H

出版信息

Neuron. 2019 Apr 3;102(1):263. doi: 10.1016/j.neuron.2019.03.020.

DOI:10.1016/j.neuron.2019.03.020

PMID:30946822

Abstract

摘要

相似文献

Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality.

Neuron. 2019 Apr 3;102(1):263. doi: 10.1016/j.neuron.2019.03.020.

Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.

Mol Ther. 2016 Apr;24(4):726-35. doi: 10.1038/mt.2015.231. Epub 2015 Dec 28.

More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.

Gene Ther. 2018 Aug;25(5):392-400. doi: 10.1038/s41434-018-0028-5. Epub 2018 Jul 16.

AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model.

Cardiovasc Res. 2002 Mar;53(4):993-1001. doi: 10.1016/s0008-6363(01)00546-6.

Current development of adeno-associated viral vectors.

Drug News Perspect. 2005 Jun;18(5):311-6. doi: 10.1358/dnp.2005.18.5.917326.

Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions.

Discov Med. 2013 Jun;15(85):379-89.

Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.

Trans Am Clin Climatol Assoc. 2003;114:337-51; discussion 351-2.

Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma.

Gynecol Oncol. 2006 Dec;103(3):1054-62. doi: 10.1016/j.ygyno.2006.06.020. Epub 2006 Jul 25.

Adeno-associated virus (AAV) as a vector for gene transfer into glial cells of the human central nervous system.

Gene Ther. 1994;1 Suppl 1:S80.

Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.

Acta Orthop Suppl. 2007 Apr;78(325):1-64.

引用本文的文献

Can Sex-based Variations in the Immune Responses to AAV Gene Therapy Affect Safety and Efficacy? A Review of Current Understanding.

AAPS J. 2025 Sep 10;27(6):141. doi: 10.1208/s12248-025-01127-5.

Systemically delivered lipid nanoparticle-mRNA encoding lysosomal acid β-glucosidase restores the enzyme deficiency in a murine Gaucher disease model.

Gene Ther. 2025 Jul 3. doi: 10.1038/s41434-025-00549-2.

Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1.

Hum Gene Ther. 2025 Apr;36(7-8):729-737. doi: 10.1089/hum.2024.233. Epub 2025 Feb 27.

Oligodendrocytes, the Forgotten Target of Gene Therapy.

Cells. 2024 Nov 28;13(23):1973. doi: 10.3390/cells13231973.

Translating Molecular Approaches to Oligodendrocyte-Mediated Neurological Circuit Modulation.

Brain Sci. 2024 Jun 27;14(7):648. doi: 10.3390/brainsci14070648.

Optimization of systemic AAV9 gene therapy in Niemann-Pick disease type C1 mice.

bioRxiv. 2024 Jun 8:2024.06.07.597901. doi: 10.1101/2024.06.07.597901.

Comparison of different promoters to improve AAV vector-mediated gene therapy for neuronopathic Gaucher disease.

Hum Mol Genet. 2024 Aug 18;33(17):1467-1480. doi: 10.1093/hmg/ddae081.

Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.

Trends Mol Med. 2024 May;30(5):459-470. doi: 10.1016/j.molmed.2024.03.005. Epub 2024 Apr 5.

Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo.

Nucleic Acids Res. 2024 Jan 25;52(2):977-997. doi: 10.1093/nar/gkad1125.

Chemogenetic Attenuation of Acute Nociceptive Signaling Enhances Functional Outcomes Following Spinal Cord Injury.

J Neurotrauma. 2024 May;41(9-10):1060-1076. doi: 10.1089/neu.2023.0141. Epub 2023 Dec 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验